Dr. Hiroaki Takizawa, Director of Shonan Beauty Clinic Omotesando Oculus, Presents Research Findings at “The 69th Annual Meeting of Japan Society of Plastic and Reconstructive Surgery”
Sharing an Individualized, Customer-Tailored Surgical Approach to Address Multiple Contributing Factors in Eyelid Surgery
IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that Dr. Hiroaki Takizawa, Director of Shonan Beauty Clinic Omotesando Oculus, presented his research at “The 69th Annual Meeting of the Japan Society of Plastic and Reconstructive Surgery,” held over three days from April 22 to 24, 2026, in Tokushima, Japan.
The Japan Society of Plastic and Reconstructive Surgery is one of Japan's largest medical societies, encompassing plastic surgery, aesthetic surgery, and regenerative medicine, among other related specialties. At its annual meeting, physicians and researchers from across the country convene to share the latest advances in treatment techniques and clinical knowledge. At the 69th Annual Meeting, Dr. Takizawa presented under the title: "Treating Puffy Eyelids: A Combined Approach of Sub-Brow Skin Excision with Orbicularis Oculi Muscle Flap Elevation and Fixation."
Eyelid puffiness often involves multiple contributing factors, including the condition of fat deposits and underlying musculature, requiring individualized treatment approaches tailored to each customer's unique anatomy. The presentation introduced a surgical approach that combines sub-brow skin excision with a technique to elevate and fixate the surrounding orbicularis oculi muscle flap, supported by clinical case examples. Dr. Takizawa also addressed the aesthetic outcomes achieved through this combination of procedures, as well as the philosophy behind delivering a fully customized treatment plan—drawing significant interest from fellow attendees.
As technological innovation continues to accelerate in the field of aesthetic healthcare, the importance of knowledge sharing and academic collaboration—beyond the clinical setting alone—has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also broad perspectives and flexible thinking. SBC Medical remains committed to advancing cutting-edge initiatives through academic presentations and research collaborations, and to upholding the safety, transparency, and enduring value of aesthetic healthcare.
Overview of “The 69th Annual Meeting of the Japan Society of Plastic and Reconstructive Surgery”
Venue: Awagin Hall / JR Hotel Clement Tokushima, and other venues
Dates: Wednesday, April 22 – Friday, April 24, 2026
Official website: https://convention.jtbcom.co.jp/jsprs69/
Presentation Title
Treating Puffy Eyelids: A Combined Approach of Sub-Brow Skin Excision with Orbicularis Oculi Muscle Flap Elevation and Fixation
About Dr. Hiroaki Takizawa
He specializes in periocular rejuvenation procedures and has accumulated extensive surgical experience across a broad range of cases in plastic and reconstructive surgery. He is known for his customer-centered approach, tailoring each treatment plan to the individual's lifestyle and recovery preferences.
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Medical Services Organization operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp